Mark Stein
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer (NCT05077098) | Mark Stein | 2021-08-12 |
| REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer (NCT03951831) | Mark Stein | 2019-05-16 |
| Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) (NCT03689699) | Mark Stein | 2018-10-11 |
Track Mark Stein automatically
Every clearance here is in the API, with alerts when new ones post.